People using weight loss injections, specifically GLP-1RA drugs, are being urged to take a good look at their diet. These ...

Xavier said that patients are often reluctant to quit smoking because they are fearful that they will gain weight. By adding ...

Columnist Jen Cueva talks with her friend Lynda Pinto, who has PH, about Lynda's experience with GLP-1 agonist medications.

New review confirms psychiatric safety of commonly used glucagon-like peptide 1 receptor agonists among patients without ...

The pricey medications remain out of reach for millions of patients across the country who could benefit from them.

The popularity of cottage cheese recipes, protein powders, and even Khloé Kardashian's popcorn launch prove a shift toward a ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

Injectable drugs like Ozempic and Mounjaro have transformed obesity treatment by mimicking gut hormones. But experts have ...

Treating nicotine addiction with glucagon-like peptide 1 receptor agonists is associated with less weight gain compared with ...

The supply of GLP-1 drugs for weight loss and diabetes treatment is expected to tighten this week with a federal deadline to ...

The recent decision by some US states to cover glucagon-like peptide-1 (GLP-1) agonists for obesity treatment marks a shift ...

SaveHealth explores the historical trajectory of weight loss drugs, examining their scientific basis, regulatory battles, public reception, and what lies ahead for pharmacotherapy in obesity ...